IZEA Worldwide, Inc.
IZEA Worldwide, Inc. (IZEA) Financial Performance & Income Statement Overview
Analyze IZEA Worldwide, Inc. (IZEA) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
IZEA Worldwide, Inc. (IZEA) Income Statement & Financial Overview
Review IZEA Worldwide, Inc. IZEA income statement with detailed quarterly and annual figures.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $11.003M | $8.83M | $9.09M | $6.95M |
| Cost of Revenue | $6.85M | $5.21M | $5.40M | $4.17M |
| Gross Profit | $4.15M | $3.62M | $3.69M | $2.78M |
| Gross Profit Ratio | $0.38 | $0.41 | $0.41 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $177629.00 |
| SG&A Expenses | $6.73M | $8.72M | $6.58M | $6.84M |
| Operating Expenses | $7.33M | $12.98M | $6.58M | $6.84M |
| Total Costs & Expenses | $14.18M | $18.19M | $11.98M | $11.01M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2475.00 | $1654.00 | $1999.00 | $2001.00 |
| Depreciation & Amortization | $489378.00 | $239849.00 | $225748.00 | $204186.00 |
| EBITDA | -$4.39M | -$8.56M | -$2.06M | -$3.08M |
| EBITDA Ratio | -$0.40 | -$0.97 | -$0.23 | -$0.55 |
| Operating Income | -$3.18M | -$9.35M | -$2.89M | -$4.06M |
| Operating Income Ratio | -$0.29 | -$1.06 | -$0.32 | -$0.58 |
| Other Income/Expenses (Net) | -$1.70M | $552288.00 | $606184.00 | $774023.00 |
| Income Before Tax | -$4.88M | -$8.80M | -$2.28M | -$3.28M |
| Income Before Tax Ratio | -$0.44 | -$1.00 | -$0.25 | -$0.47 |
| Income Tax Expense | -$253947.00 | -$33621.00 | -$88296.00 | -$18782.00 |
| Net Income | -$4.62M | -$8.77M | -$2.19M | -$3.27M |
| Net Income Ratio | -$0.42 | -$0.99 | -$0.24 | -$0.47 |
| EPS | $0.00 | -$0.52 | -$0.13 | -$0.20 |
| Diluted EPS | $0.00 | -$0.52 | -$0.13 | -$0.20 |
| Weighted Avg Shares Outstanding | $16.96M | $16.96M | $16.44M | $16.33M |
| Weighted Avg Shares Outstanding (Diluted) | $16.96M | $16.96M | $16.44M | $16.33M |
Financial performance has remained strong, with revenue growing from $6.95M in Q4 2023 to $11.003M in Q3 2024. Gross profit continued to perform well, with margins at 38% in the latest quarter. Operating income reached -$3.18M in Q3 2024, holding a steady -29% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$4.39M. Net income rose to -$4.62M, keeping EPS at $0.00. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan